These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 26513595)

  • 21. The roles of cytochrome P450 enzymes in prostate cancer development and treatment.
    Chen TC; Sakaki T; Yamamoto K; Kittaka A
    Anticancer Res; 2012 Jan; 32(1):291-8. PubMed ID: 22213318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IDENTIFICATION OF VDR ANTAGONISTS AMONG NUCLEAR RECEPTOR LIGANDS USING VIRTUAL SCREENING.
    Teske K; Nandhikonda P; Bogart JW; Feleke B; Sidhu P; Yuan N; Preston J; Goy R; Han L; Silvaggi NR; Singh RK; Bikle DD; Cook JM; Arnold LA
    Nucl Receptor Res; 2014; 1():. PubMed ID: 25419525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D metabolism and activity as well as genetic variants of the vitamin D receptor (VDR) in chronic kidney disease patients.
    Santoro D; Caccamo D; Gagliostro G; Ientile R; Benvenga S; Bellinghieri G; Savica V
    J Nephrol; 2013; 26(4):636-44. PubMed ID: 22976524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined sequence and sequence-structure based methods for analyzing FGF23, CYP24A1 and VDR genes.
    Nagamani S; Singh KhD; Muthusamy K
    Meta Gene; 2016 Sep; 9():26-36. PubMed ID: 27114920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid Dynamic Pharmacophore Models as Effective Tools to Identify Novel Chemotypes for Anti-TB Inhibitor Design: A Case Study With Mtb-DapB.
    Choudhury C; Bhardwaj A
    Front Chem; 2020; 8():596412. PubMed ID: 33425853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Prevalence of Kidney Cysts in Patients With CYP24A1 Deficiency.
    Hanna C; Potretzke TA; Cogal AG; Mkhaimer YG; Tebben PJ; Torres VE; Lieske JC; Harris PC; Sas DJ; Milliner DS; Chebib FT
    Kidney Int Rep; 2021 Jul; 6(7):1895-1903. PubMed ID: 34307984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Concern: "Discovery of small molecules through pharmacophore modeling, docking and molecular dynamics simulation against
    Heliyon; 2021 May; 7(5):e06855. PubMed ID: 34027201
    [No Abstract]   [Full Text] [Related]  

  • 29. Potent Human Telomerase Inhibitors: Molecular Dynamic Simulations, Multiple Pharmacophore-Based Virtual Screening, and Biochemical Assays.
    Shirgahi Talari F; Bagherzadeh K; Golestanian S; Jarstfer M; Amanlou M
    J Chem Inf Model; 2015 Dec; 55(12):2596-610. PubMed ID: 26529120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacophore modeling, virtual screening, molecular docking studies and density functional theory approaches to identify novel ketohexokinase (KHK) inhibitors.
    Kavitha R; Karunagaran S; Chandrabose SS; Lee KW; Meganathan C
    Biosystems; 2015 Dec; 138():39-52. PubMed ID: 26521124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The identification of c-Abl inhibitors as potential agents for Parkinson's disease: a preliminary in silico approach.
    Rymbai E; Roy D; Jupudi S; Srinivasadesikan V
    Mol Divers; 2024 Jan; ():. PubMed ID: 38273156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of BACE-1 Inhibitors against Alzheimer's Disease through E-Pharmacophore-Based Virtual Screening and Molecular Dynamics Simulation Studies: An Insilco Approach.
    Chidambaram K
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Developments and Applications of the MMPBSA Method.
    Wang C; Greene D; Xiao L; Qi R; Luo R
    Front Mol Biosci; 2017; 4():87. PubMed ID: 29367919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A theoretical insight to understand the molecular mechanism of dual target ligand CTA-018 in the chronic kidney disease pathogenesis.
    Nagamani S; Muthusamy K
    PLoS One; 2018; 13(10):e0203194. PubMed ID: 30286109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High throughput virtual screening and E-pharmacophore filtering in the discovery of new BACE-1 inhibitors.
    Muthusamy K; Singh KhD; Chinnasamy S; Nagamani S; Krishnasamy G; Thiyagarajan C; Premkumar P; Anusuyadevi M
    Interdiscip Sci; 2013 Jun; 5(2):119-26. PubMed ID: 23740393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E-Pharmacophore mapping and docking studies on Vitamin D receptor (VDR).
    Nagamani S; Kesavan C; Muthusamy K
    Bioinformation; 2012; 8(15):705-10. PubMed ID: 23055614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular disease in chronic kidney failure: the role of VDR activators.
    Wu-Wong JR; Tian J; Nakane M; Ma J; Fey TA; Kroeger P; Fryer RM; Reinhart GA
    Curr Opin Investig Drugs; 2006 Mar; 7(3):206-13. PubMed ID: 16555680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E-pharmacophore filtering and molecular dynamics simulation studies in the discovery of potent drug-like molecules for chronic kidney disease.
    Nagamani S; Muthusamy K; Marshal JJ
    J Biomol Struct Dyn; 2016 Oct; 34(10):2233-2250. PubMed ID: 26513595
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.